Primary inguinal hernia
Showing 9976 - 10000 of >10,000
Coronary Microvascular Disease, Myocardial Infarction Trial in Spain (Drug-mediated hyperemia, Flow-mediated hyperemia)
Recruiting
- Coronary Microvascular Disease
- Myocardial Infarction
- Drug-mediated hyperemia
- Flow-mediated hyperemia
-
Hospitalet de Llobregat, Barcelona, Spain
- +4 more
Oct 19, 2021
Microbiome, Anxiety and Cognitive Orientation Study
Recruiting
- Anxiety
- +4 more
-
Irvine, CaliforniaEndominance Inc.
Dec 12, 2022
Sexual Dysfunction, Physiological, Body Image, Libido; Loss, Aversion Trial in Knoxville (Hypnotic Relaxation Intervention
Recruiting
- Sexual Dysfunction, Physiological
- +2 more
- Hypnotic Relaxation Intervention (HRI)
- Vulvovaginal Atrophy (VVA)
-
Knoxville, TennesseeUniversity of Tennessee Knoxville
Jan 19, 2023
Atrial Fibrillation Trial in Cairo (Metformin, Placebo)
Not yet recruiting
- Atrial Fibrillation
- Metformin
- Placebo
-
Cairo, EgyptArab Contractors Medical Centre
May 25, 2023
Postoperative Pain Trial in Denizli (Magnesium Sulfate, normal saline isotonic solution)
Completed
- Postoperative Pain
- Magnesium Sulfate
- normal saline isotonic solution
-
Denizli, TurkeyPamukkale Univercity Medical School
May 25, 2023
Spinal Cord Injury Trial in Nottwil ([LO-LONG], [HI-SHORT)
Recruiting
- Spinal Cord Injury
- [LO-LONG]
- [HI-SHORT
-
Nottwil, LU, SwitzerlandSwiss Paraplegic Centre
Feb 24, 2022
Gonarthrosis; Primary Trial in Istanbul, Istanbul, Nevsehir (Tenoxicam 20 Mg Powder for Solution for Injection Vial,
Completed
- Gonarthrosis; Primary
- Tenoxicam 20 Mg Powder for Solution for Injection Vial
- +2 more
-
Istanbul, Kozyatağı, Turkey
- +2 more
Mar 22, 2022
Glaucoma, Age-related Macular Degeneration, Retinitis Pigmentosa Trial in Guangzhou (New head-mounted visual aids)
Not yet recruiting
- Glaucoma
- +3 more
- New head-mounted visual aids
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen University
Oct 7, 2023
Severe Hemophilia B Trial in Worldwide (Factor IX (rFIXFc), rFIX)
Spastic Paraplegia Type 50 Trial in Toronto (MELPIDA)
Active, not recruiting
- Spastic Paraplegia Type 50
- MELPIDA
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Oct 5, 2023
Mental Health, Gender-Based Violence, and Stunting in Tanzania
Completed
- Mental Health Issue
- +2 more
-
Fort Collins, ColoradoColorado State University
Oct 6, 2023
Ultrasound and Nerve Stimulator Techniques for Nerve
Withdrawn
- Orthopedic
-
New Orleans, LouisianaOchsner Clinic Foundation
Apr 19, 2022
Osteoarthrosis, Pain, Arthritis Trial in Denmark, Finland, Sweden (Hip Arthroplasty)
Active, not recruiting
- Osteoarthrosis
- +2 more
- Hip Arthroplasty
-
Aalborg, Denmark
- +4 more
Feb 4, 2022
Atrial Fibrillation Trial in Budapest (QDot Micro Catheter)
Recruiting
- Atrial Fibrillation
- QDot Micro Catheter
-
Budapest, HungarySemmelweis University
Jul 11, 2022
Lung Transplant; Complications, Primary Graft Dysfunction Trial in Milan (PEEP)
Not yet recruiting
- Lung Transplant; Complications
- Primary Graft Dysfunction
- PEEP
-
Milan, ItalyFondazione IRCCS Ca'Granda - Ospedale Maggiore Policlinico
Jan 11, 2023
Tobacco Use Trial in Worcester (Regulated ad condition, Unregulated ad condition)
Recruiting
- Tobacco Use
- Regulated ad condition
- Unregulated ad condition
-
Worcester, MassachusettsUMass Chan Medical School Stevens Lab
Jun 22, 2022
Diabetes, Type 2 Trial (LIBERATE)
Not yet recruiting
- Diabetes Mellitus, Type 2
- LIBERATE
- (no location specified)
Aug 11, 2022
Pain, Postoperative, Anesthesia, Local, Hernia, Ventral Trial in Auckland (device, drug, other)
Withdrawn
- Pain, Postoperative
- +5 more
- AutoFuser Pain Pump
- +2 more
-
Auckland, New ZealandManukau Surgical Centre, Middlemore Hospital
Sep 26, 2019
Classical Hodgkin Lymphoma Trial in China (Tislelizumab)
Completed
- Classical Hodgkin Lymphoma
-
Beijing, Beijing, China
- +10 more
Oct 18, 2021
Lung Cancer, Mesothelioma Trial in Houston (Alisertib)
Completed
- Lung Cancer
- Mesothelioma
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 23, 2022
NSCLC Trial in Shanghai (Furmonertinib 160mg, Furmonertinib 240mg)
Recruiting
- NSCLC
- Furmonertinib 160mg
- Furmonertinib 240mg
-
Shanghai, ChinaShanghai Chest hospital
Jan 16, 2023
Fibrodysplasia Ossificans Progressiva Trial (Garetosmab, Placebo)
Recruiting
- Fibrodysplasia Ossificans Progressiva
- Garetosmab
- Placebo
-
Nagoya, Aichi, Japan
- +1 more
Jan 17, 2023
Chronic Kidney Disease stage4, Chronic Kidney Disease Stage 5, Hyperkalemia Trial in Stockholm (sodium zirconium cyclosilicate
Recruiting
- Chronic Kidney Disease stage4
- +2 more
- sodium zirconium cyclosilicate and healthy diet
-
Stockholm, SwedenKarolinska Institutet
Jan 16, 2023